Articles in Peptide Bioavailability
Nasal Atomizer Devices for Peptide Delivery: Research Overview
Research on nasal atomizer and mucosal atomization device (MAD) for peptide delivery — droplet size, absorptio…
Peptide Bioavailability: Comparing Nasal, Oral, Subcutaneous, and IP Routes
Pre-clinical data comparing peptide bioavailability across nasal, oral, subcutaneous, and intraperitoneal admi…
Nanoparticle-Based Nasal Peptide Delivery: Research on Encapsulation Systems
Pre-clinical research on nanoparticle systems for nasal peptide delivery — PLGA, lipid nanoparticles, polymeri…
Nasal pH and Peptide Absorption: Formulation and Ionization Research
How nasal cavity pH affects peptide absorption — ionization states, mucosal charge interactions, formulation p…
Growth Hormone Secretagogues: Nasal vs Injectable Delivery Research
Pre-clinical comparison of nasal vs injectable delivery for growth hormone secretagogues — bioavailability rat…
Oxytocin and Vasopressin Intranasal Research: Neuropeptide Delivery Models
Pre-clinical and human research on intranasal oxytocin and vasopressin delivery — CNS uptake pathways, behavio…
Chitosan in Nasal Peptide Delivery: Mucoadhesion and Absorption Enhancement
Research on chitosan as a nasal peptide delivery excipient — mucoadhesive properties, tight junction opening, …
Mucociliary Clearance and Peptide Nasal Delivery: Residence Time Research
How mucociliary clearance affects nasal peptide delivery — residence time limitations, formulation strategies …
PT-141 (Bremelanotide) Nasal Delivery: From Research Peptide to Clinical Study
History and science of PT-141 (bremelanotide) as a nasally delivered melanocortin peptide — original pre-clini…
Cyclodextrins as Nasal Peptide Delivery Enhancers: Research Review
Research on cyclodextrins as nasal delivery enhancers for peptides — solubility improvement, permeation enhanc…
Peptide Stability in Nasal Formulations: Enzymatic Degradation Research
How peptides degrade in nasal formulations — mucosal enzymes, pH effects, aminopeptidases, and formulation str…
Subcutaneous vs Intranasal Peptide Delivery: Route Comparison Research
Pre-clinical comparison of subcutaneous and intranasal peptide delivery routes — bioavailability ratios, onset…
Blood-Brain Barrier Bypass: Intranasal Peptide Delivery to the CNS
How intranasal peptide delivery can bypass the blood-brain barrier — olfactory and trigeminal pathways, nose-t…
Selank Nasal Administration: Bioavailability and Pharmacokinetic Research
Pre-clinical and published research on Selank intranasal administration — how the anxiolytic peptide is delive…
Semax Intranasal Delivery: Russian Research and Bioavailability Studies
Review of published research on Semax nasal delivery — the Russian neuropeptide developed for intranasal use, …
BPC-157 Intranasal Delivery: What Administration Route Research Shows
Review of BPC-157 administration route research including nasal delivery considerations — bioavailability comp…
Nasal Absorption Enhancers in Peptide Delivery Research
Research on nasal absorption enhancers — chitosan, cyclodextrins, surfactants, and tight junction modulators s…
Intranasal Insulin Research: CNS Delivery Without Systemic Effects
Pre-clinical and early human research on intranasal insulin delivery — how it bypasses systemic circulation to…
Peptide Molecular Weight and Nasal Absorption: What the Research Shows
How peptide molecular weight affects nasal absorption — permeation thresholds, size exclusion effects, and pub…
Nasal Mucosa as a Drug Delivery Route: Anatomy and Absorption Science
How the nasal mucosa functions as a drug delivery route — anatomy, blood supply, lymphatic drainage, and what …
Nasal Peptide Delivery Research: Mechanisms, Absorption, and Applications
A research overview of nasal peptide delivery — absorption mechanisms, mucosal permeation, bioavailability dat…